ArticleInternal medicine (Tokyo, Japan)2019
Pazopanib Confers a Progression-free Survival in a Patient with Ewing's Sarcoma/Primitive Neuroectodermal Tumor of the Lung.
Article in Internal medicine (Tokyo, Japan), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 21 citations in OpenAlex.
- Ewing sarcoma presenting in the lung: a case report.Journal of medical case reports · 2024Article
- Activity of pazopanib inOncoscience · 2023Article
- Primary lung cancer in children and adolescents: Analysis of a surveillance, epidemiology, and end results database.Frontiers in oncology · 2023Article
- A rare radiotherapy-sensitive primitive neuroectodermal tumor withThe Journal of international medical research · 2022Review
- Article
- Primary EWS/PNET of the lung with TP53 germline and SKT11 somatic mutation: A case report and review of the literature.Thoracic cancer · 2022Review
- Application of Anlotinib Combined With Neoadjuvant Chemotherapy in Primary EWS/PNET of Lung: A Case Report.Frontiers in oncology · 2022Article
- Primary pulmonary Ewing's sarcoma: rare cause of massive hemothorax in a young girl-case report.BMC pediatrics · 2021Article
- Primary Ewing's sarcoma of the lung: a rare case report.Indian journal of thoracic and cardiovascular surgery · 2020Article
- Primitive neuroectodermal tumors of the abdominal wall and vulva in children: Report of two cases and review of the literature.World journal of clinical cases · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ewing's sarcoma (ES)/primitive neuroectodermal tumors (PNETs) are highly malignant neoplasms that usually affect the bones and soft tissues in children and young adults. ES/PNET of the lung is very rare and is associated with a poor prognosis. We herein report a case of ES/PNET of the left lung in a 45-year-old man. He was treated with neoadjuvant chemotherapy and pneumonectomy, but unfortunately his disease recurred 1.5 months after surgery. He was started on pazopanib, which resulted in a five-month progression-free survival. To our knowledge, this is the first demonstration of pazopanib efficacy in ES/PNET of the lung.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.